HR 6973 · 117th Congress · Health

Enhanced Access to Affordable Medicines Act of 2022

Introduced 2022-03-08· Sponsored by Rep. Carter, Earl L. "Buddy" [R-GA-1]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2022-03-09)

Plain Language Summary

[AI summary unavailable — showing source text] Enhanced Access to Affordable Medicines Act of 2022 This bill specifies that the Food and Drug Administration may approve generic drugs with different labels than the brand-name versions if, among other requirements, the brand-name drug is subject to an active patent or exclusivity period and a revised label for the brand-name drug is approved within 90 days (rather than 60 days) of the expiration of the patent or exclusivity period.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (1)

1 Democrat
Rep. Craig, Angie [D-MN-2]MN